8. Barrett’s Oesophagus
📄 Definition
Barrett’s oesophagus is a premalignant condition where the normal squamous epithelium of the distal oesophagus is replaced by metaplastic columnar epithelium (intestinal metaplasia) due to chronic gastro-oesophageal reflux. It significantly increases the risk of oesophageal adenocarcinoma.
🛡️ Risk Factors (Mnemonic: BARRETT)
Barrett’s or oesophageal cancer in family
Age over 50
Reflux (chronic GORD symptoms ≥5 years)
Race – White ethnicity
Elevated BMI (central obesity)
Tobacco smoking
Truncal fat distribution (android obesity)
📋 Clinical Features (Mnemonic: GORD++)
Most cases are asymptomatic and diagnosed incidentally on OGD for GORD.
GORD symptoms: heartburn, regurgitation, dysphagia
Odynophagia (rare)
Reflux resistant to PPIs
Dyspepsia or chest discomfort
++ = Associated risk of progression to dysplasia or carcinoma
⚠️ Red Flag Features (Mnemonic: ALARM55)
Refer for urgent upper GI endoscopy (OGD) if any of the following are present:
Anaemia (iron-deficiency)
Loss of weight (unintentional)
Anorexia
Recent-onset progressive dysphagia
Melaena or haematemesis
Age ≥55 with new-onset upper GI symptoms
Also refer if:
Male ≥50 with long-standing GORD + risk factors (e.g. central obesity, smoking)
🔬 Investigations
OGD with biopsy:
Seattle protocol (4-quadrant biopsies every 1–2 cm)
Confirms intestinal metaplasia with goblet cells
Histology: classify as
Non-dysplastic
Low-grade dysplasia (LGD)
High-grade dysplasia (HGD)
Management (Mnemonic: MAP)
Monitor (endoscopic surveillance)
Non-dysplastic: every 3–5 years
LGD: every 6–12 months or consider treatment if confirmed by two pathologists
HGD or early cancer: urgent endoscopic therapy
Acid suppression
Long-term PPI therapy for all patients
Symptom control and may reduce dysplasia progression
Procedure (if dysplasia)
Radiofrequency ablation (RFA) – preferred for flat dysplasia
Endoscopic mucosal resection (EMR) – for nodular areas
Consider oesophagectomy for early cancer if endoscopic therapy not appropriate
❗ Complications (Mnemonic: CANCER)
Carcinoma (oesophageal adenocarcinoma)
Anaemia (chronic GI bleeding)
Need for lifelong surveillance
Complications of endoscopic treatment (strictures, bleeding)
Esophagitis (recurrent)
Reflux persists despite therapy
Last updated in line with NICE CKS: Dyspepsia – reflux and BSG Barrett’s Oesophagus surveillance guidelines
Published: May 2010 • Last updated: April 2023
Last reviewed: July 2025
PASSMAP ensures all content is NICE-aligned and reviewed for Physician Associate Registration Assessment (PARA) success.
